Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes

Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes

US Patent 11666592 · Granted Jun 6, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy for diseases caused by unbalanced nucleotide pools including mitoch2025
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2025
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2025
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2025
Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion 2023
Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion 2023
Hybrid electro-optic wireline cable2022
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2021
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2021
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2021
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2019
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools inclu2019